In Pharma We (Don’t) Trust
Consumer trust in pharma nosedives because of the “blame game”
Roisin McGuigan, Joanna Cummings |
The 2018 Trust Barometer Survey from PR and marketing firm Edelman reports that trust in pharma in the US has seen the biggest drop yet in the five years since they started tracking it. Edelman assesses consumer trust in a variety of sectors, including the media, government, and healthcare, with pharma forming one sub-sector of the Health category. A 13-point drop in trust from 51 in 2017 to 38 in 2018 percent saw the pharma industry go from neutral into firmly distrusted territory – and pharma was also the least trusted sub-sector of healthcare in general. Internationally, consumer feeling towards pharma remained unchanged, at a neutral 55 percent – but across the globe, 80 percent of respondents reported that they felt that pharma companies placed profits ahead of patients, and 17 of 28 markets surveyed saw trust in healthcare overall decline (1).
It wasn’t bad news in all markets – South Korea and Japan both saw significant increases in trust in pharmaceuticals, due to factors including adoption of anti-corruption regulations, new medicines becoming available, and marketing reforms.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.